लोड हो रहा है...

Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide

Multiple myeloma is a hematologic malignancy that predominantly affects older adults, with a median age at diagnosis of 70 years old. A mainstay of multiple myeloma treatment is lenalidomide, which is an immunomodulatory drug (IMiD) that changed the treatment paradigm for multiple myeloma. This is p...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Interv Aging
मुख्य लेखकों: Schoenbeck, Kelly L, Wildes, Tanya M
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove 2020
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7210019/
https://ncbi.nlm.nih.gov/pubmed/32440105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S196087
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!